Donoghue Forlines’s Nu Skin NUS Stock Holding History

Donoghue Forlines’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-34,077	Closed	-$1.8M	–	228
2021 Q1	$1.8M	Buy	+34,077	New	+$1.86M	0.35%	69

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Donoghue Forlines's NUS Position: Q2 2021 in Review

Donoghue Forlines sold out of Nu Skin (NUS) in Q2 2021, closing a stake of 34,077 shares — an estimated $1.8M sold.

Donoghue Forlines first reported a position in NUS in Q1 2021 and held it in 1 quarter. The position peaked at $1.8M in Q1 2021. 273 funds tracked by Wall St. Rank hold NUS as of Q2 2021.

Donoghue Forlines reported no remaining Nu Skin position as of Q2 2021 after selling out during the quarter.
Donoghue Forlines sold 34,077 Nu Skin shares in Q2 2021, an estimated $1.8M.
Donoghue Forlines first reported a position in Nu Skin in Q1 2021 and held it in 1 quarter.
Donoghue Forlines's Nu Skin position peaked at $1.8M in Q1 2021.
273 funds tracked by Wall St. Rank held Nu Skin as of Q2 2021.

Based on Donoghue Forlines's 13F filing for Q2 2021, filed 16 Aug 2021.